发明名称 Induced pluripotent stem cells
摘要 Described herein is a major breakthrough in nuclear reprogramming and induced pluripotent stem cell (iPSC) technology. Fusion of the powerful transcription activation domain (TAD) of MyoD to the Oct4 protein makes iPSCs generation faster, more efficient, purer, safer and feeder-free. Also, disclosed herein is the first report of the use of a TAD fused to a transcription factor as a method for making iPSCs. By combining transcription factors and TADs, this approach to nuclear reprogramming can have a range of applications from inducing pluriopotency to inducing transdifferentiation without transitioning through iPSCs.
申请公布号 US9580689(B2) 申请公布日期 2017.02.28
申请号 US201113811572 申请日期 2011.07.22
申请人 Regents of the University of Minnesota 发明人 Kikyo Nobuaki;Hirai Hiroyuki
分类号 C12N5/00;C12N5/074;C07K14/47;C12N15/85 主分类号 C12N5/00
代理机构 Schwegman Lundberg & Woessner, P.A. 代理人 Schwegman Lundberg & Woessner, P.A.
主权项 1. A method to increase efficiency of reprogramming cells to form induced pluripotent stem cells (iPSC) comprising a) introducing i) a nucleic acid encoding a fusion protein comprising a transactivation domain from MyoD fused to the N-terminus or C-terminus of Oct4 operably linked to a promoter, and ii) at least one nucleic acid encoding Sox2, Klf4, and optionally c-Myc operably linked to a promoter into a somatic cell, wherein the somatic cell expresses the nucleic acids of i) and ii); and b) culturing said somatic cell for a time to reprogram into a pluripotent stein cell, wherein the fusion protein increases the efficiency of reprogramming the somatic cell into a iPSC.
地址 St. Paul MN US